BioStock: Magle Group on Q2: ”We saw a perfect storm of one-time effects”
6 augusti, 09:02
6 augusti, 09:02
Last Friday, Magle Group published its Q2 report, which showed results below market expectations, impacted by delays in high-value customer orders and raw material shortages. At the same time, the company continues to invest in its core areas – DSM, biopolymers, and stem cell technologies. BioStock invited Aaron Wong, CFO of Magle Group, to the studio to comment on the quarter.
See the interview with Aaron Wong here biostock.se:
https://biostock.se/en/2025/08/magle-group-on-q2-we-saw-a-perfect-storm-of-one-time-effects/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
6 augusti, 09:02
Last Friday, Magle Group published its Q2 report, which showed results below market expectations, impacted by delays in high-value customer orders and raw material shortages. At the same time, the company continues to invest in its core areas – DSM, biopolymers, and stem cell technologies. BioStock invited Aaron Wong, CFO of Magle Group, to the studio to comment on the quarter.
See the interview with Aaron Wong here biostock.se:
https://biostock.se/en/2025/08/magle-group-on-q2-we-saw-a-perfect-storm-of-one-time-effects/
Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!
About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.
BioStock – Connecting Innovation & Capital.
Analys
Novo Nordisk
Bostadsmarknaden
Trumps handelskrig
Inflationen
Fonder
Aktieråd
Analys
Novo Nordisk
Bostadsmarknaden
Trumps handelskrig
Inflationen
Fonder
Aktieråd
1 DAG %
Senast
Nyfosa
Igår, 16:35
Nyfosas VD köper aktier
OMX Stockholm 30
1 DAG %
Senast
2 602,98